Analysis of Ribocyclib Study for Localized Breast Cancer Treatment

Analyzing the impact of ribocyclib on localized breast cancer treatment, focusing on adverse events, treatment discontinuation rates, and therapeutic effects like LFT changes, neutropenia, and QTC prolongation. The chapter compares the study to previous trials, discusses standard care adjustments, and stresses the importance of further research on overall survival data.